CRMP-2 inhibitors constitute a class of chemical compounds specifically designed to target and modulate the activity of the collapsin response mediator protein 2 (CRMP-2). Also known as dihydropyrimidinase-related protein 2 (DPYSL2), CRMP-2 is a cytosolic phosphoprotein with critical functions in various cellular processes, particularly in neuronal development, axonal guidance, and regulation of microtubule dynamics. The chemical structures of CRMP-2 inhibitors can vary widely, and their design often involves careful consideration of the key functional groups required to interact with the active site of CRMP-2. Some inhibitors may be natural products from plants or microorganisms, while others are synthetically designed molecules tailored to bind specifically to CRMP-2. Researchers employ a diverse array of methodologies to identify and develop CRMP-2 inhibitors, including computational techniques, high-throughput screening, and rational drug design.
Mechanistically, CRMP-2 inhibitors aim to interfere with the phosphorylation or cleavage of CRMP-2, which are essential post-translational modifications involved in its activity. By targeting these regulatory processes, the inhibitors may alter CRMP-2's interactions with other cellular proteins and its involvement in neuronal signaling pathways. Furthermore, some CRMP-2 inhibitors may act indirectly by affecting downstream signaling pathways or interacting with other molecular partners that interact with CRMP-2. As part of the ongoing research, studies utilize in vitro and cellular assays to assess the potency, selectivity, and mode of action of CRMP-2 inhibitors. Moreover, structural biology techniques, such as X-ray crystallography or NMR spectroscopy, are employed to elucidate the three-dimensional interactions between CRMP-2 and its inhibitors. By deciphering the precise roles and interactions of CRMP-2 in different cellular contexts, researchers hope to gain valuable insights into the complex processes that govern neuronal growth, plasticity, and connectivity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium, commonly used as a mood stabilizer in bipolar disorder, has been shown to inhibit CRMP-2 phosphorylation, which is essential for its function in axonal guidance. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine has been shown to reduce CRMP-2 phosphorylation by inhibiting Cdk5 activity. | ||||||
Fasudil, Monohydrochloride Salt | 105628-07-7 | sc-203418 sc-203418A sc-203418B sc-203418C sc-203418D sc-203418E sc-203418F | 10 mg 50 mg 250 mg 1 g 2 g 5 g 10 g | $18.00 $33.00 $87.00 $168.00 $253.00 $496.00 $910.00 | 5 | |
Fasudil is a Rho kinase (ROCK) inhibitor that has been studied for its potential CRMP-2 modulation. | ||||||
(−)-Huperzine A | 102518-79-6 | sc-200183 sc-200183A | 1 mg 5 mg | $143.00 $362.00 | 1 | |
Huperzine A is a natural acetylcholinesterase inhibitor and has been investigated for its neuroprotective effects, which may involve CRMP-2 regulation. | ||||||
K-252a | 99533-80-9 | sc-200517 sc-200517B sc-200517A | 100 µg 500 µg 1 mg | $129.00 $214.00 $498.00 | 19 | |
K252a is a natural product that has been found to inhibit CRMP-2 phosphorylation by inhibiting the activity of various kinases. | ||||||
Erbstatin Analog | 63177-57-1 | sc-200511 sc-200511A | 5 mg 25 mg | $83.00 $305.00 | 4 | |
This compound has been identified as a CRMP-2 inhibitor and might have potential neuroprotective effects. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Leptomycin B is a natural product that has been found to inhibit CRMP-2 nuclear export, affecting its function in the nucleus. | ||||||
Isobavachalcone | 20784-50-3 | sc-202666 | 1 mg | $213.00 | 1 | |
Isobavachalcone is a flavonoid compound with reported CRMP-2 inhibitory activity, and it has been investigated for its potential neuroprotective effects. | ||||||